NO973873D0 - Hepatitt B vaksine - Google Patents

Hepatitt B vaksine

Info

Publication number: NO973873D0
Authority: NO; Norway
Prior art keywords: vaccine; hepatitis
Prior art date: 1995-02-25

Application number

NO973873A

Other languages

English (en)

Other versions

NO319394B1 (no

NO973873L (no

Inventor

Pierre Hauser

Nathalie Marie-Josephe Garcon

Pierre Desmons

Original Assignee

Smithkline Beecham Biolog

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-25

Filing date

1997-08-22

Publication date

1997-08-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10770292&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO973873(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-08-22 Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog

1997-08-22 Publication of NO973873D0 publication Critical patent/NO973873D0/no

1997-08-22 Publication of NO973873L publication Critical patent/NO973873L/no

2005-08-08 Publication of NO319394B1 publication Critical patent/NO319394B1/no

Links

SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 title 1
229940124736 hepatitis-B vaccine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Microbiology (AREA)
Mycology (AREA)
Immunology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO19973873A 1995-02-25 1997-08-22 Hepatitt B vaksine NO319394B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9503863.4A GB9503863D0 (en)	1995-02-25	1995-02-25	Vaccine compositions
PCT/EP1996/000681 WO1996026741A1 (en)	1995-02-25	1996-02-15	Hepatitis b vaccine

Publications (3)

Publication Number	Publication Date
NO973873D0 true NO973873D0 (no)	1997-08-22
NO973873L NO973873L (no)	1997-08-22
NO319394B1 NO319394B1 (no)	2005-08-08

Family

ID=10770292

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19973873A NO319394B1 (no)	1995-02-25	1997-08-22	Hepatitt B vaksine

Country Status (36)

Country	Link
US (1)	US5972346A (no)
EP (1)	EP0810877B1 (no)
JP (1)	JP3881015B2 (no)
KR (1)	KR100365373B1 (no)
CN (1)	CN1101225C (no)
AP (1)	AP766A (no)
AR (1)	AR002279A1 (no)
AT (1)	ATE209045T1 (no)
AU (1)	AU695921B2 (no)
BG (1)	BG101851A (no)
BR (1)	BR9607458A (no)
CA (1)	CA2212552C (no)
CZ (1)	CZ288417B6 (no)
DE (1)	DE69617211T2 (no)
DK (1)	DK0810877T3 (no)
EA (1)	EA199700126A1 (no)
ES (1)	ES2166879T3 (no)
FI (1)	FI118118B (no)
GB (1)	GB9503863D0 (no)
HK (1)	HK1004117A1 (no)
HU (1)	HU224832B1 (no)
IL (1)	IL117249A (no)
MA (1)	MA23814A1 (no)
MX (1)	MX9706450A (no)
MY (1)	MY113428A (no)
NO (1)	NO319394B1 (no)
NZ (1)	NZ302674A (no)
OA (1)	OA10612A (no)
PL (1)	PL182679B1 (no)
PT (1)	PT810877E (no)
SA (1)	SA96160633B1 (no)
SK (1)	SK115097A3 (no)
TR (1)	TR199700849T1 (no)
TW (1)	TW467745B (no)
WO (1)	WO1996026741A1 (no)
ZA (1)	ZA961460B (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6620414B2 (en) *	1992-03-27	2003-09-16	Smithkline Beecham Biologicals (S.A.)	Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
FR2711670B1 (fr)	1993-10-22	1996-01-12	Pasteur Institut	Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
US6488934B1 (en) *	1995-02-25	2002-12-03	Smithkline Beecham Biologicals S.A.	Hepatitis B vaccine
US20010014331A1 (en) *	1996-11-07	2001-08-16	Smithkline Beecham Biologicals S.A.	Acellular pertussis vaccine with diphthriae-and tetanus-toxoids
US20030049268A1 (en)	1998-05-01	2003-03-13	Smithkline Beecham Biologicals S.A.	Novel composition
GB9809507D0 (en) *	1998-05-01	1998-07-01	Smithkline Beecham Biolog	Novel composition
ES2272069T3 (es)	1998-05-22	2007-04-16	Ottawa Health Research Institute	Metodos y productos para inducir inmunidad en mucosas.
US6306404B1 (en)	1998-07-14	2001-10-23	American Cyanamid Company	Adjuvant and vaccine compositions containing monophosphoryl lipid A
EP1126876B1 (en) *	1998-10-16	2007-03-21	GlaxoSmithKline Biologicals S.A.	Adjuvant systems and vaccines
CU22871A1 (es) *	1998-12-02	2003-10-21	Ct Ingenieria Genetica Biotech	Formulaciones conteniendo partículas semejantes a virus como inmunopotenciadores por vía mucosal
EP1140155A4 (en) *	1998-12-23	2004-11-03	Merck & Co Inc	IMPROVED RECOMBINATION HEPATITIS B ENVELOPE ANTIGEN
EP2322210A1 (en)	1999-04-19	2011-05-18	GlaxoSmithKline Biologicals S.A.	Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
US6635261B2 (en)	1999-07-13	2003-10-21	Wyeth Holdings Corporation	Adjuvant and vaccine compositions containing monophosphoryl lipid A
CU23031A1 (es) *	2002-01-24	2005-02-23	Ct Ingenieria Genetica Biotech	Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes
AU2006215419B2 (en) *	2005-02-16	2012-03-08	Novartis Vaccines And Diagnostics, Inc.	Adjuvant composition comprising aluminium phosphate and 3D-MPL
AP2745A (en) *	2005-08-02	2013-09-30	Novartis Vaccines & Diagnostic	Reducing interference between oil-containing adjuvants and surfactant-containing antigens
NZ592713A (en)	2005-11-04	2012-12-21	Novartis Vaccines & Diagnostic	Adjuvanted influenza vaccines including a cytokine-inducing agents other than an agonist of Toll-Like Receptor 9
US20090304742A1 (en)	2005-11-04	2009-12-10	Novartis Vaccines And Diagnostics Srl	Influenza vaccines with reduced amount of emulsion adjuvant
PT1951299E (pt)	2005-11-04	2012-02-28	Novartis Vaccines & Diagnostic	Vacinas contra a gripe que incluem combinações de adjuvantes particulados e imuno-potenciadores
EP2368572B1 (en)	2005-11-04	2020-03-04	Seqirus UK Limited	Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
CN100415294C (zh) *	2005-12-23	2008-09-03	中国农业大学	一种治疗和/或预防乙肝的药物
KR20110110853A (ko)	2006-01-27	2011-10-07	노파르티스 파르마 아게	적혈구응집소 및 기질 단백질을 함유한 인플루엔자 백신
CA2646539A1 (en)	2006-03-23	2007-09-27	Novartis Ag	Imidazoquinoxaline compounds as immunomodulators
JP2009534303A (ja)	2006-03-24	2009-09-24	ノバルティスヴァクシンズアンドダイアグノスティクスゲーエムベーハーアンドカンパニーカーゲー	冷蔵しないインフルエンザワクチンの保存
EP1862176A1 (de) *	2006-05-31	2007-12-05	Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH	Ein Verfahren zur Herstellung einer Impfzusammensetzung
EP1862177A1 (de) *	2006-06-01	2007-12-05	Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH	Ein Verfahren zur Herstellung einer Impfzusammensetzung
PT2054431E (pt)	2006-06-09	2011-11-03	Novartis Ag	Confórmeros de adesinas bacterianas
GB0614460D0 (en)	2006-07-20	2006-08-30	Novartis Ag	Vaccines
AU2007297178B2 (en)	2006-09-11	2014-07-24	Novartis Ag	Making influenza virus vaccines without using eggs
CA2671629C (en)	2006-12-06	2017-08-15	Novartis Ag	Vaccines including antigen from four strains of influenza virus
AU2008269439B2 (en)	2007-06-27	2013-12-19	Novartis Ag	Low-additive influenza vaccines
GB0810305D0 (en)	2008-06-05	2008-07-09	Novartis Ag	Influenza vaccination
GB0818453D0 (en)	2008-10-08	2008-11-12	Novartis Ag	Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
AU2008339631B2 (en)	2007-12-24	2014-07-24	Novartis Ag	Assays for adsorbed influenza vaccines
AR077757A1 (es)	2009-07-15	2011-09-21	Novartis Ag	Composiciones de proteinas de fusion del virus sincicial respiratorio (rsv) y metodos para su preparacion
WO2012103361A1 (en)	2011-01-26	2012-08-02	Novartis Ag	Rsv immunization regimen
US9452212B2 (en)	2011-04-14	2016-09-27	Dynavax Technologies Corporation	Methods and compositions for eliciting an immune response against hepatitis B virus
HUE034673T2 (en)	2011-05-13	2018-02-28	Glaxosmithkline Biologicals Sa	Pre-fusion rsv f antigens
WO2016207853A2 (en)	2015-06-26	2016-12-29	Seqirus UK Limited	Antigenically matched influenza vaccines
US12128100B2 (en)	2018-11-13	2024-10-29	Variation Biotechnologies Inc.	Immunogenic compositions for treatment of Hepatitis B

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4912094B1 (en) *	1988-06-29	1994-02-15	Ribi Immunochem Research Inc.	Modified lipopolysaccharides and process of preparation
DE69031556T2 (de) *	1989-07-25	1998-05-14	Smithkline Beecham Biologicals S.A., Rixensart	Antigene sowie Verfahren zu deren Herstellung
JP3307392B2 (ja) *	1991-05-29	2002-07-24	オリジン・メドシステムズ・インク	内視鏡による手術用の器官後退装置
MY111880A (en) *	1992-03-27	2001-02-28	Smithkline Beecham Biologicals S A	Hepatitis vaccines containing 3-0 deacylated monophosphoryl lipid a
ES2118963T3 (es) *	1992-05-23	1998-10-01	Smithkline Beecham Biolog	Vacunas combinadas, que contienen antigeno de superficie de la hepatitis b y otros antigenos.
ATE204762T1 (de) *	1993-03-23	2001-09-15	Smithkline Beecham Biolog	3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen
GB9311536D0 (en) *	1993-06-04	1993-07-21	Unilever Plc	Hot soluble low density extractable food product

1995
- 1995-02-25 GB GBGB9503863.4A patent/GB9503863D0/en active Pending
1996
- 1996-02-14 MY MYPI96000567A patent/MY113428A/en unknown
- 1996-02-15 KR KR1019970705880A patent/KR100365373B1/ko not_active IP Right Cessation
- 1996-02-15 EP EP96904814A patent/EP0810877B1/en not_active Expired - Lifetime
- 1996-02-15 CZ CZ19972674A patent/CZ288417B6/cs not_active IP Right Cessation
- 1996-02-15 ES ES96904814T patent/ES2166879T3/es not_active Expired - Lifetime
- 1996-02-15 AU AU48780/96A patent/AU695921B2/en not_active Ceased
- 1996-02-15 TR TR97/00849T patent/TR199700849T1/xx unknown
- 1996-02-15 CN CN96192146A patent/CN1101225C/zh not_active Expired - Fee Related
- 1996-02-15 SK SK1150-97A patent/SK115097A3/sk unknown
- 1996-02-15 EA EA199700126A patent/EA199700126A1/ru unknown
- 1996-02-15 CA CA002212552A patent/CA2212552C/en not_active Expired - Fee Related
- 1996-02-15 US US08/894,643 patent/US5972346A/en not_active Expired - Lifetime
- 1996-02-15 PL PL96321966A patent/PL182679B1/pl unknown
- 1996-02-15 PT PT96904814T patent/PT810877E/pt unknown
- 1996-02-15 BR BR9607458A patent/BR9607458A/pt not_active IP Right Cessation
- 1996-02-15 DE DE69617211T patent/DE69617211T2/de not_active Expired - Lifetime
- 1996-02-15 WO PCT/EP1996/000681 patent/WO1996026741A1/en active IP Right Grant
- 1996-02-15 AP APAP/P/1997/001060A patent/AP766A/en active
- 1996-02-15 JP JP52598896A patent/JP3881015B2/ja not_active Expired - Fee Related
- 1996-02-15 DK DK96904814T patent/DK0810877T3/da active
- 1996-02-15 HU HU9801242A patent/HU224832B1/hu not_active IP Right Cessation
- 1996-02-15 NZ NZ302674A patent/NZ302674A/xx not_active IP Right Cessation
- 1996-02-15 AT AT96904814T patent/ATE209045T1/de active
- 1996-02-22 AR ARP960101469A patent/AR002279A1/es active IP Right Grant
- 1996-02-23 IL IL11724996A patent/IL117249A/xx not_active IP Right Cessation
- 1996-02-23 ZA ZA961460A patent/ZA961460B/xx unknown
- 1996-02-23 MA MA24171A patent/MA23814A1/fr unknown
- 1996-02-26 TW TW085102154A patent/TW467745B/zh not_active IP Right Cessation
- 1996-03-02 SA SA96160633A patent/SA96160633B1/ar unknown
1997
- 1997-08-02 OA OA70066A patent/OA10612A/en unknown
- 1997-08-22 FI FI973457A patent/FI118118B/fi not_active IP Right Cessation
- 1997-08-22 MX MX9706450A patent/MX9706450A/es unknown
- 1997-08-22 NO NO19973873A patent/NO319394B1/no not_active IP Right Cessation
- 1997-08-25 BG BG101851A patent/BG101851A/xx unknown
1998
- 1998-04-28 HK HK98103600A patent/HK1004117A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
HUP9801242A1 (hu)	1998-08-28
IL117249A (en)	2000-11-21
KR100365373B1 (ko)	2003-07-07
JP3881015B2 (ja)	2007-02-14
AP9701060A0 (en)	1997-10-31
KR19980702480A (ko)	1998-07-15
PL182679B1 (pl)	2002-02-28
DK0810877T3 (da)	2002-02-25
CN1176604A (zh)	1998-03-18
EP0810877B1 (en)	2001-11-21
AR002279A1 (es)	1998-03-11
EA199700126A1 (ru)	1998-02-26
IL117249A0 (en)	1996-06-18
WO1996026741A1 (en)	1996-09-06
BR9607458A (pt)	1998-06-30
DE69617211T2 (de)	2002-07-25
MA23814A1 (fr)	1996-10-01
AP766A (en)	1999-09-17
PT810877E (pt)	2002-04-29
MX9706450A (es)	1998-07-31
NO319394B1 (no)	2005-08-08
OA10612A (en)	2002-08-29
HUP9801242A3 (en)	2000-08-28
SA96160633B1 (ar)	2005-10-15
BG101851A (en)	1998-04-30
EP0810877A1 (en)	1997-12-10
GB9503863D0 (en)	1995-04-19
FI973457A0 (fi)	1997-08-22
DE69617211D1 (en)	2002-01-03
AU695921B2 (en)	1998-08-27
TR199700849T1 (xx)	1998-01-21
HK1004117A1 (en)	1998-11-20
CZ267497A3 (cs)	1998-02-18
HU224832B1 (en)	2006-03-28
MY113428A (en)	2002-02-28
ZA961460B (en)	1996-08-29
AU4878096A (en)	1996-09-18
PL321966A1 (en)	1998-01-05
NO973873L (no)	1997-08-22
FI973457A (fi)	1997-08-22
ATE209045T1 (de)	2001-12-15
FI118118B (fi)	2007-07-13
US5972346A (en)	1999-10-26
ES2166879T3 (es)	2002-05-01
CN1101225C (zh)	2003-02-12
SK115097A3 (en)	1998-02-04
NZ302674A (en)	1999-01-28
CZ288417B6 (en)	2001-06-13
CA2212552C (en)	2006-07-11
CA2212552A1 (en)	1996-09-06
TW467745B (en)	2001-12-11
JPH11501018A (ja)	1999-01-26

Publication	Publication Date	Title
DK0810877T3 (da)	2002-02-25	Hepatitis B-vaccine
NO976060D0 (no)	1997-12-23	Vaksiner mot hepatitt C
NO20003303L (no)	2000-08-04	Vaksine
BR9711853A (pt)	1999-08-24	Vacinas
KR970704468A (ko)	1997-09-06	폴리에피토프 백신(polyepitope vaccines)
ID20399A (id)	1998-12-10	Vaksin influensa
DE69126606D1 (de)	1997-07-24	Vakzine
DK0736303T3 (da)	2000-01-10	Interferonopløsning
DE69510024D1 (de)	1999-07-08	Spritze
FI944052A (fi)	1994-09-02	Oraalinen rokote
EP0967993A4 (en)	2001-04-18	ANTI-COCAINE VACCINE
ATE253641T1 (de)	2003-11-15	Antigenische präparationen
DE69509766D1 (de)	1999-06-24	Mikroemulsionen
DE69628167D1 (de)	2003-06-18	Spezifische oligonukleotide fuer hepatitis c-virus
IT1276662B1 (it)	1997-11-03	Vaccini polinucleotidici
NO933600D0 (no)	1993-10-08	Termostabile virus
ITMI950511A0 (it)	1995-03-16	Fotodensitometro parallelo perfezionato
SI0810877T1 (en)	2002-06-30	Hepatitis b vaccine
DE69326536D1 (de)	1999-10-28	Antitumor Impfstoff
FI944558A0 (fi)	1994-09-30	Virus
UA24703A (uk)	1998-10-30	Емітерний повторювач
NO980721D0 (no)	1998-02-20	Vaksiner
BR7502544U (pt)	1998-05-05	Easy baby
KR970703417A (ko)	1997-07-03	유두종 바이러스 백신(Papillomavirus vaccines)
SE9501165D0 (sv)	1995-03-31	Hållaranordning

Legal Events

Date	Code	Title	Description
2016-02-22	MK1K	Patent expired